At meeting held on 10 November 2016
Lincoln Pharmaceuticals announced that the Board of Directors of the Company at their meeting held on 10 November 2016, had considered and approved the following:- The proposal of Delisting of Equity Shares of the Company from Ahmedabad Stock Exchange pursuant to SEBI (Delisting of Equity Shares) Regulations, 2009 as amended from time to time.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
